Larissa Comis
Product Lead for the Cognizant Shared Investigator Platform (SIP)
Cognizant
Larissa Comis is a clinical trial technology expert with 20 years in the Life Sciences, Healthcare and Software/Technology industries, with a focus in oncology. She has worked with all constituents in the life sciences industry including life sciences professionals, patients, doctors, nurses and payers.
Larissa has deep experience working with Life Sciences customers who are ready to make the investment in clinical trials technology platforms. She worked with customers to create business cases that articulate the value and return on investment in increased efficiencies, decreased risk and improved cost savings across the clinical trial continuum. She also worked with leading CROs to determine what measurable benefits they and their investigators could achieve by moving to an enterprise wide electronic eConsent solution that was interconnected with their EDC and eCOA.
Prior to joining Cognizant, Larissa developed and implemented global go-to-market strategies for Thomson Reuters Cortellis Clinical Trials Intelligence and for Medidata Solutions. She also worked with the National Cancer Institute on several national clinical trial technology initiatives.
Larissa has a passion for improving the clinical trials experience for investigators. Her own father was a global thought leader, who, as an oncologist, led some of the world’s leading clinical trials research organizations.
Larissa holds a BA from William Smith College and a Master of Journalism from Temple University.
Larissa has deep experience working with Life Sciences customers who are ready to make the investment in clinical trials technology platforms. She worked with customers to create business cases that articulate the value and return on investment in increased efficiencies, decreased risk and improved cost savings across the clinical trial continuum. She also worked with leading CROs to determine what measurable benefits they and their investigators could achieve by moving to an enterprise wide electronic eConsent solution that was interconnected with their EDC and eCOA.
Prior to joining Cognizant, Larissa developed and implemented global go-to-market strategies for Thomson Reuters Cortellis Clinical Trials Intelligence and for Medidata Solutions. She also worked with the National Cancer Institute on several national clinical trial technology initiatives.
Larissa has a passion for improving the clinical trials experience for investigators. Her own father was a global thought leader, who, as an oncologist, led some of the world’s leading clinical trials research organizations.
Larissa holds a BA from William Smith College and a Master of Journalism from Temple University.